Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach
{{output}}
Oral esketamine is a potentially effective and well-tolerated treatment for treatment-resistant depression (TRD). However, around 50% of TRD individuals treated with oral esketamine do not achieve response, and this variation in response may be accounted for b... ...
